Author of the publication

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , and 27 other author(s). Clinical Cancer Research, (September 2014)Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas., , , , , , , , , and 4 other author(s). Genome Biol, 9 (10): R150 (2008)Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients., , , , , , , , , and 2 other author(s). Clin Cancer Res, 12 (1): 131--138 (January 2006)Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks, , , , , , , , , and 1 other author(s). Nat Med, 7 (6): 673--679 (June 2001)Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification., , , , , , , , , and 4 other author(s). J Clin Oncol, 24 (31): 5070--5078 (November 2006)High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status., , , , , , , , , and 4 other author(s). Clin Cancer Res, 13 (16): 4695--4703 (August 2007)Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , and 27 other author(s). Clin Cancer Res, 21 (8): 1904-1915 (April 2015)Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified disease., , , , , , , , , and 1 other author(s). Cancer Lett, 250 (2): 250--267 (June 2007)